Transsexualität

Asscheman H, Gooren LJG, Assies J, Smits JPH, De Slegte R (1988) Prolactin levels and pituitary enlargement in hormone-treated mal-to-female transsexuals. Clin Endocrinol 28: 583–588Google Scholar

Bakker A, van Kesteren PJ, Gooren LJ, Bezemer PD (2002) The prevalence of transsexualism in the Netherlands. Acta Psychiatr Scand 87: 237–238Google Scholar

Cohen-Kettenis PT, Gooren LJ (1999) Transsexualism: a review of etiology, diagnosis and treatment. J Psychosom Res 46: 315–333CrossRefPubMedGoogle Scholar

Damewood MD, Bellantoni JJ, Bachorik PS, Kimball AW Jr, Roch JA (1989) Exogenous estrogen effect on lipid/lipoprotein cholesterol in transsexual males. J Endocrinol Invest 12: 449–454PubMedGoogle Scholar

Dorner G, Poppe I, Stahl F, Kolzsch J, Uebelhack R (1991) Gene-and environment-dependent neuroendocrine etiogenesis of homosexuality and transsexualism. Exp Clin Endocrinol 98: 141–150PubMedGoogle Scholar

Eicher W, Schmitt B, Bergner CM (1991) Transformationsoperation bei Mann-zu-Frau-Transsexuellen. Z Sexualforsch 4: 119–132Google Scholar

Eicher W (1992) Transsexualismus, 2. Auflage. Gustav Fischer, StuttgartGoogle Scholar

Gesetz über die Änderung der Vornamen und die Feststellung der Geschlechtszugehörigkeit in besonderen Fällen (Transsexuellengesetz — TSG) (1980) Bundesgesetzblatt, Jahrgang 1980, Teil IGoogle Scholar

Goh HH, Ratnam SS (1990) Effects of estrogens on prolactin secretion in transsexual subjects. Arch Sex Behav 19: 507–516PubMedGoogle Scholar

Kemper J (1992) Sexualtherapeutische Praxis. J. Pfeiffer, MünchenGoogle Scholar

Kokott G (1988) Sexuelle Variationen. In: Faust V (Hrsg) Psychiatrie für den Praxisalltag. Hippokrates, Stuttgart, S 63–78Google Scholar

Kovacs K (1999) Prolactin-producing pituitary adenoma in a male-to-femaletranssexual patient with protracted estrogen administration. Arch Pathol Lab Med 118: 562–565Google Scholar

Liedl B (1999) Geschlechtsangleichende Operationen bei Transsexualität. MMW Fortschr Med 41(23): 305–309Google Scholar

Moore E, Wisniewski A, Dobs A (2003) Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab 88: 3467–3473CrossRefPubMedGoogle Scholar

Pfäfflin F (1993) Transsexualität. Enke, StuttgartGoogle Scholar

Poland D (1991) Transsexualität — Leitsymptomatik, Differentialdiagnostik und Behandlungskonzepte. In: Kamprad B; Schiffels W (Hrsg) Im falschen Körper. Alles über Transsexualität. Keuz, Zürich, S 70–83Google Scholar

Schlatterer K, Werder K von, Stalla GK (1996) Multistepp treatment concept of transsexual patients. Clin Endocrinol Diabetes 104: 413–419Google Scholar

Schlatterer K, Auer DP, Yassouridis A, Werder K von, Stalla GK (1998) Transsexualism and osteoporosis. Clin Endocrinol Diabetes 106: 365–368Google Scholar

Schlatterer K, Yassouridis A, Werder K von, Poland D, Kemper J, Stalla GK (1998) A follow-up study for estimating the effectiveness of a crossgender hormone substitution therapy on transsexual patients. Arch Sex Behav 27(5), 475–492CrossRefPubMedGoogle Scholar

Sigusch V (1994) Leitsymptome transsexueller Entwicklungen. Dtsch Ärztebl 91(20): B1085–B1088Google Scholar

Toorians AWFT, Thomassen MCLGD, Zweegman S, Magdelyns EJP, Tans G, Gooren LJ, Rosing J (2003) Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. J Clin Endocrinol Metab 88: 5723–5729PubMedGoogle Scholar

Van Kesteren PJ, Asscheman H, Megens JA, Gooren LJ (1997) Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol 47: 337–342Google Scholar

Zhou JN, Hofman MA, Gooren LJ, Swaab DF (1995) A sex difference in the human brain and its relation to transsexuality. Nature 378: 68–70PubMedGoogle Scholar